News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Mario Balsa: Breaking from ASCO 2025 – DESTINY-Gastric04 Trial
Mario Balsa/X
Jun 1, 2025, 11:35

Mario Balsa: Breaking from ASCO 2025 – DESTINY-Gastric04 Trial

Mario Balsa, Medical Oncology resident at ICO, Shared a post on X:

“Breaking from ASCO25 — DESTINY-Gastric04
T-DXd outperforms RAM+PTX in 2L HER2+ advanced G/GEJ cancer:
mOS: 14.7 vs 11.4 mo (HR: 0.70, p=0.004)
mPFS: 6.7 vs 5.6 mo
cORR: 44.3% vs 29.1%
DCR: 91.9% vs 75.9%
A new standard? Eureka, you found it.”

Mario balsa

Read OncoDaily’s Special Articles about ASCO25:

Highlights from ASCO 2025 Day 1

Highlights from ASCO 2025 Day 2

ASCO

ASCO ASCO25 cancer Mario Balsa OncoDaily Oncology
Special Coverage
Oncolibrary
Jun 25, 2025, 10:27
The Day After a Nuclear Bomb: Generational Damage and the Silent Cancer Epidemic
Blog
Jun 25, 2025, 10:00
Scientific Advisory Board Members - World Bladder Cancer Patient Coalition
Science
Jun 25, 2025, 09:58
Prerna Mewawalla: Excited to Share our Multicenter Study on Real-world Outcomes of Sequential BCMA Therapies in RRMM After Belantamab
Insight
Jun 25, 2025, 09:52
Shruti Patel: Who Decides Who Decides?
Blog
Jun 25, 2025, 09:42
Krishna Soujanya Gunturu Co-Leads a Reopened S2013 ICHECKIT Cancer Trial - SWOG Cancer Research Network
Science
Jun 25, 2025, 09:39
Chad Pecot: A First-in-Class EGFR-Directed KRAS G12V Selective Inhibitor
Science
Jun 25, 2025, 09:27
Mario Balsa: Real-world Comparison in Advanced HCC - Atezolizumab + Bevacizumab vs Tremelimumab + Durvalumab
Blog
Jun 25, 2025, 09:08
Laura Bukavina: How Do We Predict Patients with True CR Using Urine Biomarkers?
Science
Jun 25, 2025, 09:08
Myeloma Paper of the Day, June 25th, suggested by Robert Orlowski
Blog
Jun 25, 2025, 09:07
Mikkael Sekeres: Can BPAs, PFAS, or Phthalates in Everyday Household Items Can Cause Cancer?
Insight
Jun 25, 2025, 09:00
Stephen V Liu on Phase 2 Study of Irinotecan plus Anlotinib for Platinum-Resistant SCLC
Insight
Jun 25, 2025, 08:59
David Tougeron Shared Study on Prognostic Tool for Third-Line Chemotherapy in Unresectable Pancreatic Cancer